novel
coronaviru
diseas
spread
japan
collect
total
patient
requir
extracorpor
membran
oxygen
ecmo
avail
data
first
case
demonstr
median
age
patient
median
pao
fio
ratio
posit
endexpiratori
pressur
mean
airway
pressur
lung
complianc
cmh
cmh
mlcmh
respect
median
serum
level
uml
consequ
wean
extub
rehabilit
remain
ecmo
seem
two
phenotyp
one
impair
lung
complianc
one
preserv
lung
complianc
latter
phenotyp
like
favor
use
ecmo
investig
necessari
clasrifi
optim
use
ecmo
patient
novel
coronaviru
diseas
spread
japan
number
patient
need
extracorpor
membran
oxygen
ecmo
expect
increas
howev
clinic
characterist
patient
requir
benefit
ecmo
unclear
februari
japanes
societi
intens
care
medicin
jsicm
japanes
associ
acut
medicin
jaam
japanes
societi
respiratori
care
medicin
jsrcm
japanes
societi
pcp
ecmo
jspcpsecmo
launch
japan
ecmonet
telephon
consult
treatment
support
webbas
realtim
nationwid
registri
surveil
system
discuss
patient
hospit
may
candid
ecmo
initi
led
ecmo
expert
japan
ecmonet
japan
march
patient
place
ecmo
base
deliber
group
sixteen
wean
six
extub
rehabilit
rest
remain
ecmo
patient
wean
ecmo
still
need
treatment
organ
failur
report
data
first
case
median
age
patient
rang
year
median
number
day
intub
ecmo
day
rang
day
median
pao
fio
ratio
peep
mean
airway
pressur
lung
complianc
initi
ecmo
rang
cmh
rang
cmh
cmh
cmh
mlcmh
rang
mlcmh
respect
select
laboratori
data
patient
admiss
follow
median
serum
marker
interstiti
pneumonia
uml
ldh
iul
procalcitonin
ngml
regard
ecmo
set
median
blood
flow
lmin
rang
lmin
median
size
drain
cannula
fr
rang
fr
median
size
infus
cannula
fr
rang
fr
antivir
treatment
lopinavir
use
patient
patient
receiv
empir
antibiot
carbapenem
gener
cephalosporin
ciclesonid
glucocorticoid
inhal
use
case
effect
medic
assess
time
expert
within
japan
ecmonet
identifi
two
phenotyp
patient
sever
pneumonia
one
associ
low
lung
complianc
anoth
preserv
lung
complianc
oxygen
patient
preserv
lung
complianc
improv
higher
peep
patient
serum
spd
anoth
marker
interstiti
pneumonia
ldh
elev
admiss
find
suggest
lung
fibrosi
sever
subgroup
patient
adopt
platform
realtim
discuss
guid
use
scarc
resourc
ecmo
valuabl
japanes
doctor
care
critic
ill
patient
infect
central
nearrealtim
data
repositori
optim
perform
justintim
epidemiolog
studi
develop
algorithm
inform
clinic
decisionmak
